Roivant Sciences is a biopharmaceutical company focused on realizing the full value of promising drug candidates to improve the lives of patients.

Biotechnology

Roivant Sciences

Roivant Sciences' headquarters in New York, NY, United States

The Basel office focuses on executive support and operational management for Swiss-based activities and initiatives.

Basel

Matt Gline

Richard Pulik

Stephanie Lee Griffin

Mat Bazley

Michael J. Elliot

Julia G. Butchko

Mayukh Sukhatme

Drew Kramer

Eric Venker

Chris Chapman

Julie Edelstein

Mitchell Mittman

Huafeng Xu

Colin Bower

David Nassif

Ian Rosenblum

John Alfano

Gavin Corcoran

Ruby Grewal

Elaine Wu

Intern, Roivant Health

Alex Gasner

Jo Chen

Ilan Oren

Sakshi Chhabra

George Migausky

Senthil Sundaram

Kathleen Sebelius

Keith Manchester

Donald Berwick

Thomas Daschle

Sheila Burke

Olympia Snowe

Daniel Gold

James C. Momtazee

Atul Pande

Andrew Fromkin

Melissa Epperly

Hiroshi Nomura

Berndt Modig

Pete Rouse

Douglas Hughes

This department oversees the strategic management and execution of regulatory compliance, clinical operations, and drug product development activities.

Regulatory and Clinical Affairs

The Commercial and Business Development team at Roivant Sciences is responsible for evaluating market opportunities, strategizing partnerships, and fostering collaborations to maximize the potential of the company’s biopharmaceutical assets. This team plays a critical role in driving growth by aligning commercial strategies with investment priorities and operational capabilities, ensuring that promising drug candidates reach patients effectively.

Commercial and Business Development

This department provides strategic direction and oversight for all business operations and initiatives across various sectors of the organization.

Executive Leadership

The Medical Affairs and Regulatory team at Roivant Sciences is responsible for ensuring the successful development and regulatory approval of the company's biopharmaceutical products. This team collaborates with cross-functional leaders to provide medical insights, oversee clinical trial design and execution, and communicate with regulatory bodies, ensuring compliance and alignment with industry standards. Their ultimate goal is to facilitate safe and effective treatments that enhance patient outcomes.

Medical Affairs and Regulatory

The Corporate Governance team at Roivant Sciences is responsible for ensuring effective oversight and accountability across the company’s board of directors and its various subsidiaries, including Axovant, Immunovant, and Genevant. This team plays a crucial role in shaping governance policies, facilitating communication among board members, and aligning corporate strategies with regulatory requirements to enhance transparency and ethical standards in biopharmaceutical development.

Corporate Governance

The Leadership Team at Roivant Sciences is responsible for setting the strategic direction of the company, overseeing the development and commercialization of innovative biopharmaceutical solutions, and ensuring operational excellence across all divisions. This team leverages their diverse expertise in healthcare, finance, and operations to drive growth, optimize resources, and enhance the value of drug candidates aimed at improving patient outcomes.

Leadership Team

Roivant Sciences

Org chart

Board & advisors

Teams

Regulatory and Clinical Affairs

Commercial and Business Development

Executive Leadership

Medical Affairs and Regulatory

Corporate Governance

Leadership Team

Offices

Roivant Sciences

Org chart

Board & advisors

Teams

Regulatory and Clinical Affairs

Commercial and Business Development

Executive Leadership

Medical Affairs and Regulatory

Corporate Governance

Leadership Team

Offices

Related companies